PT-141 Hilma Biocare 10 mg

PT-141 by Hilma Biocare, also known as Bremelanotide, is a peptide developed specifically to support libido and sexual arousal. Unlike PDE-5 inhibitors such as sildenafil or tadalafil, which act on blood flow, PT-141 works centrally through melanocortin receptors in the nervous system to address desire itself. That makes it useful for both men and women dealing with low sexual desire rather than purely mechanical function, and it is typically used on demand rather than daily. Supplied as 10 mg lyophilized powder.
| Active substance | PT-141 (Bremelanotide) |
| Manufacturer | Hilma Biocare |
| Strength | 10 mg per vial |
| Form | Lyophilized powder for reconstitution |
| Mechanism | Melanocortin receptor agonist |
| Use | On-demand, libido/arousal |
Effects and benefits
Because PT-141 acts on the central pathways that drive arousal, it can improve responsiveness and confidence in intimate situations for both sexes. Its desire-focused action complements — rather than replaces — the blood-flow effect of traditional ED medications.
- Supports sexual desire and arousal
- Central mechanism, not just blood flow
- Works for both men and women
- Convenient on-demand use
Usage and administration
PT-141 is reconstituted with bacteriostatic water and injected subcutaneously a short time before activity, on demand rather than on a daily schedule. As a research peptide it belongs alongside the rest of the peptides range rather than in a performance cycle.
Related products
For a complete approach, users often combine the desire-focused action of PT-141 with a blood-flow agent such as Tadalafil or Viagron.
Why choose Hilma Biocare
Each vial is produced to consistent pharmaceutical standards with reliable peptide content you can trust. Explore the full Hilma Biocare catalogue for matching products.
| Characteristics | |
| Shelf Life | 36 months from manufacture date |
| Drug Class | Melanocortin Receptor Agonist |
| Concentration | 10 mg per vial |
| Half-Life | ~120–160 min |
| Detection Time | Not typically tested in standard drug screenings |
| Active Substance | PT-141 (Bremelanotide) |
| Dosage | 1-2 mg per day |
| Drug Category | Peptide |
| Form | Lyophilized powder |
| Product Packaging | 10 mg vial |
| Liver Toxicity | None |
| Chemical Structure | Synthetic cyclic heptapeptide (Bremelanotide) |
